An optimized zebrafish obesogenic test protocol with an artificial intelligence-based analysis software for screening obesogens and anti-obesogens

Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white a...

Full description

Saved in:
Bibliographic Details
Published inBiology methods and protocols Vol. 10; no. 1; p. bpaf052
Main Authors Al Kassir, Sara, Mercé, Théo, Pedemay, Sandra, Bourcier, Laure M, Soares, Magalie, Le Mentec, Hélène, Podechard, Normand, Knoll-Gellida, Anja, Babin, Patrick J
Format Journal Article
LanguageEnglish
Published England Oxford University Press 2025
Subjects
Online AccessGet full text
ISSN2396-8923
2396-8923
DOI10.1093/biomethods/bpaf052

Cover

Loading…
Abstract Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software (ZOTAS) was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
AbstractList Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software (ZOTAS) was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the rise in obesity is the exposure to endocrine disruptors acting as obesogens. Semitransparent zebrafish larvae, with their well-developed white adipose tissue (WAT), offer a unique opportunity for studying the effects of toxicant chemicals and pharmaceuticals on adipocyte dynamics and whole-organism adiposity in a vertebrate model. The work presented here is a detailed optimized zebrafish obesogenic test (ZOT) protocol. The method allows to assess the effects of diet composition, drugs and environmental contaminants, acting as obesogens or anti-obesogens, alone or in combination, on WAT levels in zebrafish larvae. Zootechnical parameter guidelines, including larvae rearing conditions, feeding, and selection of larvae to be enrolled are provided. An optimized procedure for in vivo staining of adipocyte lipid droplets with Nile Red before and after exposure to compounds is provided to enhance reproducibility. Using suitable subcutaneous WAT locations, a rationally defined guide for wide-field fluorescence microscopy signal acquisition is proposed. The ZOT analysis software was developed to enable automated and efficient image data processing by using custom-trained supervised deep-learning models. The present ZOT protocol distinguishes intrinsic variability of the test method from the biological effect measured. It is the basis of a specific, sensitive, and robust quantitative in vivo assay for high-throughput screening of compounds and food content that influence adipocyte hyper/hypotrophy. As such, it provides relevant information for environmental as well as human risk and benefit assessments.
Author Al Kassir, Sara
Mercé, Théo
Bourcier, Laure M
Soares, Magalie
Knoll-Gellida, Anja
Podechard, Normand
Babin, Patrick J
Pedemay, Sandra
Le Mentec, Hélène
Author_xml – sequence: 1
  givenname: Sara
  surname: Al Kassir
  fullname: Al Kassir, Sara
– sequence: 2
  givenname: Théo
  surname: Mercé
  fullname: Mercé, Théo
– sequence: 3
  givenname: Sandra
  surname: Pedemay
  fullname: Pedemay, Sandra
– sequence: 4
  givenname: Laure M
  surname: Bourcier
  fullname: Bourcier, Laure M
– sequence: 5
  givenname: Magalie
  surname: Soares
  fullname: Soares, Magalie
– sequence: 6
  givenname: Hélène
  surname: Le Mentec
  fullname: Le Mentec, Hélène
– sequence: 7
  givenname: Normand
  surname: Podechard
  fullname: Podechard, Normand
– sequence: 8
  givenname: Anja
  surname: Knoll-Gellida
  fullname: Knoll-Gellida, Anja
– sequence: 9
  givenname: Patrick J
  orcidid: 0000-0002-7411-2297
  surname: Babin
  fullname: Babin, Patrick J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40799311$$D View this record in MEDLINE/PubMed
https://hal.science/hal-05162357$$DView record in HAL
BookMark eNpdkstuFDEQRS0URELID7BAltjAokn50a8VGkVAkEZiA2vLdtvTjrrtxvYkSj6DL8bDDEPIylb5-Fbp1n2JTnzwBqHXBD4Q6NmlcmE2eQxDulSLtFDTZ-iMsr6pup6yk0f3U3SR0g0AkI7XBMgLdMqh7XtGyBn6tfI4LNnN7sEM-MGoKK1LIw7KpLAx3mmcTcp4iSEHHSZ85_KIpccyZmeddnLCzmczTa7Q2lRKpiIkvZzuk0s4BZvvZDTYhoiTjqZI-s1RPhVyR2dXHUuv0HMrp2QuDuc5-vH50_er62r97cvXq9W60owxWjHVEN5b1cBQd72iHVdcMVuzltRgSQetrhtNzWBVp4xqqBxAwdBJoC2VkrFz9HGvu2zVbAZtfI5yEkt0s4z3Ikgn_n_xbhSbcCsIZZwB8KLwfq8wPvl3vVqLXQ1q0lBWt7eksO8O3WL4uS2WitklXXyT3oRtEqzsi1DC276gb5-gN2Ebi6N_qK4FwnlTqDePxz_2_7vbAtA9oGNIKRp7RAiIXYbEvwyJQ4bYb2WdwL8
ContentType Journal Article
Copyright The Author(s) 2025. Published by Oxford University Press.
The Author(s) 2025. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution - NonCommercial
The Author(s) 2025. Published by Oxford University Press. 2025
Copyright_xml – notice: The Author(s) 2025. Published by Oxford University Press.
– notice: The Author(s) 2025. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution - NonCommercial
– notice: The Author(s) 2025. Published by Oxford University Press. 2025
DBID AAYXX
CITATION
NPM
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
7X8
1XC
5PM
DOI 10.1093/biomethods/bpaf052
DatabaseName CrossRef
PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection (ProQuest)
ProQuest Central
Natural Science Collection (ProQuest)
ProQuest One
ProQuest Central
ProQuest Central Student
SciTech Premium Collection (ProQuest)
Biological Sciences
Biological science database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
CrossRef


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2396-8923
ExternalDocumentID PMC12343004
oai_HAL_hal_05162357v1
40799311
10_1093_biomethods_bpaf052
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 0R~
53G
AAFWJ
AAPXW
AAVAP
AAYXX
ABDBF
ABEJV
ABGNP
ABPTD
ABXVV
ACGFS
ACUHS
AENZO
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AMNDL
AVWKF
BAYMD
BBNVY
BENPR
BHPHI
CCPQU
CITATION
EBS
ESX
GROUPED_DOAJ
H13
HCIFZ
IAO
IHR
ISR
KSI
M7P
M~E
O9-
OAWHX
OJQWA
OK1
PEELM
PHGZM
PHGZT
PIMPY
PQGLB
RPM
TOX
EJD
ITC
NPM
8FE
8FH
ABUWG
AZQEC
DWQXO
GNUQQ
LK8
PKEHL
PQEST
PQQKQ
PQUKI
PUEGO
7X8
1XC
5PM
ID FETCH-LOGICAL-c3332-3b6149fb60d589b284b4b3f537150f1807c56c2edfb8beb62ad0b0d8a0272aa33
IEDL.DBID BENPR
ISSN 2396-8923
IngestDate Thu Aug 21 18:27:57 EDT 2025
Thu Aug 28 06:24:09 EDT 2025
Sat Aug 23 12:16:07 EDT 2025
Wed Aug 27 01:32:29 EDT 2025
Sun Aug 17 02:25:10 EDT 2025
Thu Aug 14 00:06:29 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords endocrine disruptors
ZOTAS
adipose tissue
zebrafish
ZOT
obesity
anti-obesogens
obesogens
Ecology
Biology
Test (biology)
Computer science
Medicine
Pathology
Gene
Alternative medicine
Genetics
Software
Protocol (science)
Artificial intelligence
Operating system
Language English
License https://creativecommons.org/licenses/by-nc/4.0
The Author(s) 2025. Published by Oxford University Press.
Attribution - NonCommercial: http://creativecommons.org/licenses/by-nc
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3332-3b6149fb60d589b284b4b3f537150f1807c56c2edfb8beb62ad0b0d8a0272aa33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7411-2297
0000-0002-3687-1778
0000-0002-2638-3180
OpenAccessLink https://www.proquest.com/docview/3238701446?pq-origsite=%requestingapplication%
PMID 40799311
PQID 3238701446
PQPubID 7121356
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12343004
hal_primary_oai_HAL_hal_05162357v1
proquest_miscellaneous_3239121479
proquest_journals_3238701446
pubmed_primary_40799311
crossref_primary_10_1093_biomethods_bpaf052
PublicationCentury 2000
PublicationDate 2025-00-00
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025-00-00
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Biology methods and protocols
PublicationTitleAlternate Biol Methods Protoc
PublicationYear 2025
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0001845101
Score 2.2786677
Snippet Obesity is defined as a disease in which abnormal excessive body fat accumulation causes adverse effects on health. One proposed contributing factor to the...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage bpaf052
SubjectTerms Adipocytes
Adipose tissue
Artificial intelligence
Body fat
Contaminants
Danio rerio
Deep learning
Endocrine disruptors
Fluorescence microscopy
High-throughput screening
Larvae
Life Sciences
Methods
Obesity
Toxicants
Title An optimized zebrafish obesogenic test protocol with an artificial intelligence-based analysis software for screening obesogens and anti-obesogens
URI https://www.ncbi.nlm.nih.gov/pubmed/40799311
https://www.proquest.com/docview/3238701446
https://www.proquest.com/docview/3239121479
https://hal.science/hal-05162357
https://pubmed.ncbi.nlm.nih.gov/PMC12343004
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZoKyQuqLxTSmUQN2RtYufhnKotarVCUBBqpb1FfmpzIFmabRH9GfziziTebBckLjk4o8TKTGa-GdvfEPLeAwYotNOMG29ZaoxmmvuM6cJzaR13tm_n8-U8n12mn-bZPBTcurCtcu0Te0dtW4M18omA2FIg_M-Plz8Zdo3C1dXQQmOH7IELlpB87Z2cnn_7vqmyyBSNLpyWgex90p9qx97M3UQvFUyVb0WknQXuh_wXbP69Z_JeEDrbJ48DeqTTQd1PyAPXPCUPh36Sv5-RP9OGtuADftS3ztJbXBP2dbegrXZdC5ZSGwrIckWRnKEFC6BYhaWqoWg_A5UEre9xdDKMcRYEBuIS2oHP_qWuHAWkS8HfQA4MkW98fAeSKL2q2Tj0nFyenV58nLHQdIEZIQRnQkPALr3OY5vJUkP00qkWPhMFQEefyLgwWW5Ah15L0HHOlY11bKWC_JYrJcQLstu0jXtFqMxs4ZW0tuSYRvLSOrALnphYFCIzaUQ-rD98tRy4NaphTVxUGzVVQU0ReQe6GQWRFns2_VzhGDiWHGl7bpKIHK5VV4Wfsas2phORt-Nt-I1wbUQ1rr3uZcoEezaVEXk5aHp8FeS8gOISeLjcsoGtuWzfaepFT9UNuCBFTrOD_8_rNXnEsa9wX9o5JLurq2v3BsDOSh8Fiz7qiwVwvfg6vwMGVwm-
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrRBcEP-kFDAITsjaxM7vAaEFWm3pdoVQK_WWxrGtzYFk22yp2sfgQXhGZpJstgsSt16TUeJkPs98M7ZnAN5a5ACRMoqL3Gru57niStiAq8iKWBthdNPO52Aajo_8r8fB8Qb8Xp6FoW2VS5vYGGpd5ZQjH0r0LRHR__Dj_JRT1yhaXV220GhhsW8uLzBkqz_sfUH9vhNid-fw85h3XQV4LqUUXCr0SIlVoauDOFFonpWvpA1khNzIerEb5UGY4yCtivEjQpFpV7k6zjCAE1lGCVA0-Zu-xFBmAJufdqbfvq-yOrFPIO9O57iJHDan6KkXdD1U8wx_jVjzgLdmtP_yX3L79x7Na05v9z7c69gqG7XwegAbpnwIt9v-lZeP4NeoZBXanB_FldHsitagbVHPWKVMXSEyi5whk10wKgZRIeIYZX1ZVjLCa1u6ghXXaoJy8qkaBdpCKaxGH3GRnRmGzJqhfcOYGz1t__gaJUl6UfD-0mM4uhF1PIFBWZXmGbA40JHNYq0TQWGrSLRBHAovd2Ukg9x34P3yx6fztpZH2q7By3SlprRTkwNvUDe9IJXhHo8mKV1DQxZSmaCfngPbS9Wl3eSv0xVUHXjd38ZpS2sxWWmq80Ym8ahHVOLA01bT_aswxkbW6OHD4zUMrI1l_U5ZzJrS4MhDfKqhtvX_cb2CO-PDg0k62ZvuP4e7gnoaN2mlbRgszs7NCyRaC_WyQzeDk5ueUH8AkfdD-A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+optimized+zebrafish+obesogenic+test+protocol+with+an+artificial+intelligence-based+analysis+software+for+screening+obesogens+and+anti-obesogens&rft.jtitle=Biology+methods+and+protocols&rft.au=Al+Kassir%2C+Sara&rft.au=Merc%C3%A9%2C+Th%C3%A9o&rft.au=Pedemay%2C+Sandra&rft.au=Bourcier%2C+Laure+M&rft.date=2025&rft.issn=2396-8923&rft.eissn=2396-8923&rft.volume=10&rft.issue=1&rft.spage=bpaf052&rft_id=info:doi/10.1093%2Fbiomethods%2Fbpaf052&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2396-8923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2396-8923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2396-8923&client=summon